ArticleJTCVS open2026
Clinical outcomes of pediatric heart transplantation: A 25-year follow-up experience in a Japanese institute.
Article in JTCVS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Advances in medical management have markedly improved early and late outcomes after pediatric heart transplantation. Although survival data are well established in Western countries, evidence from Asia remains limited. Methods: We retrospectively reviewed the records of 75 patients who underwent heart transplantation younger than 18 years and received posttransplant care at The University of Osaka Hospital, Japan, between 2000 and 2024. Results: The cohort included 35 male patients, with a median age of 6 years at transplantation. Forty-six patients (61%) underwent transplantation in Japan and 29 (39%) underwent transplantation in other countries. Underlying diagnoses were dilated cardiomyopathy in 42 patients (56%), restrictive cardiomyopathy in 23 (31%), and congenital heart disease in 4 (5%). Overall survival was 96% at 5 and 10 years, 86% at 15 years. Major posttransplant complications included posttransplant lymphoproliferative disease (n = 9), rejection requiring intensified immunosuppression (n = 14), cardiac allograft vasculopathy (n = 5), and renal failure requiring kidney transplantation or dialysis (n = 9). Among the 38 patients who reached adulthood, 15 (39%) were employed, 14 (37%) were pursuing higher education, and 9 (24%) were neither employed nor in education. Conclusions: Pediatric heart transplantation at our institution yielded long-term survival rates comparable with international registry data. Most patients achieved stable school attendance and successful adult social reintegration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.